NCT01531582View on ClinicalTrials.gov

Minocycline in the Treatment of Angelman Syndrome

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

September 30, 2015

Conditions
Angelman Syndrome
Interventions
DRUG

minocycline

The participant's parent or guardian will be instructed to administer minocycline caplets by mouth twice daily. Parents or guardians will be instructed to avoid dairy products, antacids, or any vitamin preparation that contains any divalent or trivalent cations (e.g. Aluminum, Calcium, Magnesium, etc.) for one hour prior to, and two hours after study medication administration.

Trial Locations (1)

33613

Univeristy of South Florida, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER

NCT01531582 - Minocycline in the Treatment of Angelman Syndrome | Biotech Hunter | Biotech Hunter